Lv3
256 积分 2022-02-12 加入
Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
1个月前
已完结
Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease
3个月前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
3个月前
已完结
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
3个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
3个月前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
3个月前
已完结
Multi-omic definition of metabolic obesity through adipose tissue–microbiome interactions
4个月前
已完结
Standardized Assessment of Energy Excretion in Healthy Adults: A Novel Methodology
4个月前
已完结
Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial
5个月前
已完结
Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trial
5个月前
已完结
Combining Medications With Bariatric Surgery to Treat Obesity
Risk Factors for Early-Onset Colorectal Cancer: A Nested Case‒Control Study within the Korean National Health Insurance Service‒Health Screening Cohort
皖公网安备34019202002308
